Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com
SOURCE Cota Inc.
Miami Cancer Institute at Baptist Health will leverage Cota's data, nodal address and analytics to deliver precision medicine and enable the best treatments at the highest quality of care for patients
NEW YORK, Jan. 3, 2018 /PRNewswire/ -- Cota Inc., a healthcare data and analytics company bridging precision medicine to population health, and Baptist Health South Florida, the largest healthcare organization in the region, today announced a multi-year agreement to advance cancer treatment and clinical research at the new Miami Cancer Institute. Cota will enhance Miami Cancer Institute's ability to deliver superior care and drive the most effective treatment for every type of cancer.
Miami Cancer Institute is improving patient access to the latest and most effective cancer treatment advances through its role in the Memorial Sloan Kettering Cancer Alliance (MSK). The Institute offers leading clinical cancer services, cutting-edge technology and a superior patient experience, in addition to leveraging Cota's market-leading Provider Solution to identify unwarranted variances at the physician and practice-level. Cota recently announced a multi-year partnership with MSK with the goal of improving patient care, advancing world-class research efforts and reducing the total cost of oncology care with actionable data and analytical insights.
The Cota Provider solution is an end-to-end oncology analytics suite comprised of real-world analytics, decision support and value based tracking. Leveraging the patented Cota Nodal AddressTM (CNA), a precision patient classification system, and Cota Real-World Evidence (RWE), the industry's leading collection of oncology patient data, the Cota Provider solution improves quality and outcomes in cancer care, increases oncology margins in fee-for-service and value-based arrangements and assists practices looking to transition to value-based care.
"Miami Cancer Institute is committed to combining the latest technology and innovation to enable personalized medicine in cancer care. That is why we selected Cota, a market leader in data and analytics. By using their Provider Solution and CNA we'll be able to generate critical insights from our data to continually improve the quality of care we deliver to our patients," said Michael J. Zinner, M.D., founding chief executive officer and executive medical director of Miami Cancer Institute.
"With the ability to see genomic-level data alongside cost and historical clinical data, Cota will help accelerate our journey to value-based care," said Leonard Kalman, M.D., executive deputy director and chief medical officer of Miami Cancer Institute. "This not only increases the level of precision in our patients' treatment journey, but it also ensures that every individual receives the highest quality of care possible which increases the odds of survivorship."
Miami Cancer Institute is the third member of the MSK Cancer Alliance, a transformative initiative that enhances the quality of cancer care and the lives of cancer patients by bringing Memorial Sloan Kettering Cancer Center's standards of care, state-of-the-art treatments and clinical trials to the community cancer center setting. This meaningful partnership will further augment Miami Cancer Institute's position as the primary destination for cancer patients in the southeastern United States, Latin America and the Caribbean.
"The benefits of leveraging the CNA will result in reducing unwarranted variation in treatments, costs and outcomes and lead to treatment standardization and notable operational improvement on a practice and physician level, setting Miami Cancer Institute apart from other providers," said Andrew Norden, M.D., chief medical officer at Cota. "The use of Cota through the lens of the CNA enables physicians and other health care professionals to deliver care resulting in optimal clinical outcomes for every individual patient and to reduce the total cost of care for the population being served."
Cota has partnered with organizations like Miami Cancer Institute across the country and continues to rapidly grow their provider network with recent additions across a mix of academic, community and non-academic institutions. To learn more about Cota's provider solutions and how Cota can work with your organization contact firstname.lastname@example.org.
Cota is a healthcare data and analytics company that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.
Cota's technology enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and medicine to improve the lives of patients everywhere. For more information, go to www.cotahealthcare.com
About Miami Cancer Institute
Baptist Health South Florida is developing Miami Cancer Institute into a destination cancer center known for its leading clinical care, compassionate patient experience, advanced clinical research and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean. To accelerate its mission of hope, caring and innovation, Miami Cancer Institute has joined the Memorial Sloan Kettering Cancer Alliance, a meaningful partnership that affords patients with cancer access to potential breakthrough therapies in South Florida. For more information, visit MiamiCancerInstitute.com.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with ten hospitals (Baptist Hospital, Baptist Children's Hospital, Bethesda Hospital East, Bethesda Hospital West, Doctors Hospital, Fishermen's Community Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), more than 40 physician practices, 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence spanning across Monroe, Miami-Dade, Broward and Palm Beach counties. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 18,500 employees and more than 3,000 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World's Most Ethical Companies. For more information, visit BaptistHealth.net/newsroom and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.
Georgi Morales Pipkin
Baptist Health South Florida
©2017 PR Newswire. All Rights Reserved.